Buyer counteroffer field guide
Expose the incentives, rebuild the economics, protect your financing ceiling, price only what transfers, and keep a credible shell or startup alternative. The goal is not an arbitrary haircut. It is a counteroffer the seller can trace line by line.
Start with incentives
A role, fee, referral, or lending relationship is not proof of bad conduct. It is a reason to ask who the professional represents, who pays them, what increases compensation, what information they receive, and what conclusion they are actually qualified to make.
ADA buyer/seller resources describe the seller retaining the broker, and an ADA cost article says business-broker fees are generally about 10% of practice value. A higher price can therefore increase a percentage-based fee. The same article describes an independent valuation as fixed-fee work whose provider does not earn more from a higher value. That does not prove broker misconduct; it does define the independence question a buyer should ask.
Protecting staff, patients, and goodwill is legitimate. Still, a buyer can require a price or defensible range, broker role, fee basis, and minimum data set before revealing maximum financing capacity, relocating, or signing exclusivity.
Approval means the lender may accept the credit and collateral risk under its terms. It does not establish that the price is fair, the buyer’s lifestyle is workable, or the clinical and payer model will transfer. ADA recommends speaking with at least three banks.
Historical revenue does not reveal provider effort, labor replacement, patient credits, payer portability, treatment philosophy, deferred capex, or buyer-repeatable cash. Reconcile the target before applying any valuation method.
If the buyer must perform the work, hire the role, replace the benefit, cure the problem, or keep the expense, it is not free cash. State the replacement cost and the record that supports it.
Confirm ownership, liens, serial numbers, service history, software dependencies, remaining life, regulatory status, removal cost, and whether the equipment fits the buyer’s workflow.
Patient activity, seller dependence, exact payer access, referral sources, phone/domain rights, team continuity, location, and transition behavior determine whether goodwill survives. No evidence of transfer means no automatic premium.
A credible startup, vacated dental shell, smaller practice, or continued employment changes the walk-away price. The seller’s package usually values the target; it rarely prices the buyer’s best alternative.
What the package can hide
Do not ask for “a discount.” Identify the seller claim, supporting document, buyer-specific case, annual or one-time dollar effect, verification state, and requested concession.
Five years of provider days, hours, procedures, and schedule exports
Price the cost and capacity needed to reproduce the seller’s work; remove temporary extra days.
Code units and dollars by provider, patient cohort, remakes, refunds, referrals, and de-identified clinical review
Remove cash flow from procedures the buyer will not perform or cannot ethically reproduce; structure uncertain retention.
Cohorts by last completed visit, recall status, provider, payer, geography, and open treatment
Do not pay the same goodwill for stale names, duplicates, emergency-only visitors, or seller-bound patients.
Completed visits, reappointment, periodontal mix, provider days, vacancies, wage offers, and room capacity
Rebase production for achievable staffing—not chairs, backlog, or wished-for hiring.
Executed contracts, exact products, fee schedules, remittances, amendments, network leasing, and credentialing path
Reprice to the buyer’s expected allowed amounts and delay; a seller’s contracted revenue may not transfer.
Aging detail, subsequent collections, prepayments, membership liabilities, refunds, recoupments, and bank cutoffs
Separate earned collectible A/R from cash pulled forward and future work already paid.
Payroll, benefits, PTO, overtime, bonuses, tenure, vacancies, market offers, and retention intentions
Deduct recurring market compensation and temporary coverage; fund retention separately when useful.
Asset register, inspection, service logs, software requirements, replacement quotes, and facility assessment
Use current replacement and remediation cost net of verified remaining value—not original invoice price.
Executed lease, amendments, assignment, options, CAM history, guarantees, use/exclusivity, restoration, and market rent
Capitalize above-market or risky terms only with qualified analysis; make assignment and landlord consent closing conditions.
Access register, audit logs, risk analysis, incidents, licenses, permits, policies, backups, and export test
Deduct the supported cure cost; escrow defined unknown liabilities; walk from blocked access or meaningless logs.
Referral source history, new-patient source, reviews, complaints, phone/domain ownership, and seller relationships
Discount or condition value that can leave with one person, one specialist, one employer, or one web asset.
Daily cash timing, payroll, lab, supplies, debt timing, payer lag, seasonality, and post-close opening plan
Do not spend the operating runway on goodwill. Require working capital in sources and uses or reduce cash at close.
Draft purchase agreement, asset schedule, entity records, independent fair-value support, and both sides’ proposed Form 8594 treatment
Model the buyer’s after-tax cost before agreeing to boilerplate allocation. The IRS generally treats a lump-sum asset sale as the sale of separate assets; allocation must follow applicable rules and consistent reporting—not simply whichever label wins the negotiation.
Never double count. A staff-wage reset may already appear in buyer-repeatable operating cash; a capital item may already be reflected in an asset valuation; lost procedures may overlap patient attrition. Keep a reconciliation column showing where each adjustment enters once.
Interactive negotiation bridge
Use target records—not percentages from a listing package. Replace the teaching inputs with independently supported figures.
“Our position is not a blanket haircut. Starting with the $850,000 ask, the records support $180,000 of recurring-value adjustment and $115,000 of immediate cost or assumed obligations. That produces an evidence-adjusted discussion point of $555,000; our downside financing case supports no more than $650,000, with $100,000 shifted from cash at close until the defined risk is resolved.”
Teaching model only. It is not an appraisal, fairness opinion, lender decision, legal recommendation, or tax allocation. Do not multiply a disputed adjustment mechanically: verify whether it is recurring, already reflected elsewhere, and appropriate under the chosen valuation method. Counsel and the lender must approve holdbacks, notes, escrows, and contingent terms.
Match remedy to risk
Do not let a complicated structure disguise a price that fails on known facts. Use structure for a defined unresolved risk, with objective measurement, a time limit, remedies, records access, and professional review.
Lower total price
Seller note or contingent slice only if the risk is measurable and lawful
Dollar-for-dollar price reduction
Specific escrow, payoff, repair before close, or indemnity
Exclude unsupported goodwill
Time-limited contingent value with objective definitions and no influence on care
Pause; do not guess
Diligence and exclusivity clocks begin after complete, usable delivery
Lower goodwill and cash at close
Defined transition, seller note, enforceable protections, and cooperation remedies
Assign zero until transfer is documented
Closing condition or separately priced replacement path
Contingent value must never reward unnecessary treatment, interfere with clinical judgment, mislead patients, or violate state ownership, fee-splitting, lender, tax, or professional rules.
Third path · buy the shell, not the goodwill
A retired, relocated, consolidated, or failed office may preserve expensive infrastructure and shorten opening time without requiring the buyer to capitalize an unverified patient story. It can also contain obsolete systems, liens, abandoned records, code problems, and landlord risk. Price the reuse—not the nostalgia.
Closed or relocated Google listings, commercial lease listings, permit histories, auction notices, public business records, and visible former dental suites.
Commercial brokers, landlords, property managers, dental equipment service technicians, distributors, labs, lenders with asset-disposition teams, and local dental networks. Ask them to pass your contact to the owner; do not ask for confidential client information.
Dentists who closed, estates, practices that moved, consolidators that vacated duplicate sites, and owners who kept real estate but never sold goodwill.
A dark office with no team, current patients, transferable contracts, or operating system is usually a startup site with legacy risk—not a going-concern practice.
This path is real, not theoretical. An ADA article describes a buyer who heard from dental supply representatives about a practice that had been closed for roughly six months, contacted the owner, and completed a direct transaction. The article calls that unusually frictionless experience a “fluke.” The durable lesson is to build an off-market discovery channel—not to skip valuation, counsel, title/lien work, records review, or facility diligence.
Patient lists, phone numbers, domains, records, and reputation receive separate value only when ownership, lawful transfer, currency, and actual utility are verified.
Track source, landlord, last operation, reuse evidence, liens, permits, remediation, opening timeline, and the all-in alternative cost.
Watchout · financing information
The operator behind DenQAI reports having evidence in a past transaction that some bank personnel shared private loan information with commonly used dental vendors or contractors. That account identifies a mechanism to investigate; it does not establish how often this occurs or that every disclosure was unlawful.
A vendor who learns the maximum approved amount, liquidity, or contingency can infer how far a buyer might stretch. Even a lawful or operationally convenient disclosure can weaken price discipline, expose personal financial details, or distort “independent” quotes.
Federal Regulation P states that its consumer-financial-privacy rules do not apply to information about companies or individuals obtaining financial services for business, commercial, or agricultural purposes. Do not assume a consumer privacy notice protects a dental-practice loan. Other law, bank policy, contract, data-security duties, and facts may still matter; use counsel.
Federal banking agencies expect banks to manage third-party relationship risk. That supervisory expectation does not answer whether a particular disclosure was authorized, necessary, confidential, harmful, or actionable in your facts.
“Before I provide additional financial information, please identify every non-bank recipient that may receive any part of my application or underwriting file, the specific data fields, purpose, legal or contractual basis, retention period, safeguards, and any referral compensation. Unless required to process or service the loan and confirmed to me in writing, please do not disclose my requested amount, approval ceiling, personal financial statement, liquidity, projections, appraisal, or vendor budget to any broker, seller, contractor, equipment vendor, consultant, or marketing/referral partner without my separate written authorization.”
Have counsel tailor this request. A bank may decline, require certain disclosures, or explain that existing documents already authorize them. The goal is informed control and a written record—not a claim that the template overrides law or contract.
Negotiation sequence
Sign a narrow NDA, identify the broker’s client and fee basis, request the asking price or range, and do not disclose maximum financing.
Screen the market, seller fit, procedure mix, staffing, site, payer access, and shell/startup alternative. A pleasant visit is not diligence.
Require a minimum data set, buyer counsel, explicit nonbinding language except identified provisions, and price subject to verification. ADA’s transition account warns that a light LOI can function as practical agreement to price.
Work from raw exports and source documents. Keep a contradiction log, assign a verification state, quantify annual versus one-time effects, and prevent double counting.
Lead with a reconciliation, not emotion: seller ask, each supported adjustment, buyer-repeatable cash, immediate obligations, affordability ceiling, proposed cash at close, and risk-specific structure.
Keep other practices, employment, startup sites, and dental shells alive until the transaction is closed and every critical dependency is satisfied.
A seller can reject a supported counter. The buyer’s leverage is the ability to decline debt that only works if the seller’s best year, easiest staffing case, and most profitable treatment pattern all continue.
Record the claim, evidence, annual or one-time effect, verification state, concession requested, seller response, and final treatment—without hiding judgment in a single multiple.
The buyer’s sentence
A seller is entitled to ask. A buyer is entitled to verify, counter, structure, or walk.
Return to complete practice diligence